24 May 2018 - 25 May 2018
Source: © Can Stock Photo Inc./adam121
Kymab's Director of Pharmacology and Translational Sciences, Richard Sainson will be presenting at the 3rd Annual Advances in Immuno-Oncology Congress
Over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies will attend the 3rd Annual Advances in Immuno-Oncology Congress.
There will be over 50 presentations and case studies focusing on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies.